# GLP-1 Drugs Linked to Temperature Regulation Problems and Hot Flashes
Users of GLP-1 medications like Ozempic and Wegovy report experiencing chills, hot flashes, and other temperature regulation problems that extend beyond the drugs' well-known gastrointestinal side effects.
These thermoregulatory issues emerge as patients lose weight rapidly on the medications. The mechanism appears tied to how the body adjusts its metabolic set point during significant weight loss. As metabolism slows, the body's temperature control system struggles to recalibrate, creating oscillating sensations of extreme cold and heat.
Healthcare providers have historically focused on nausea, vomiting, and constipation when discussing GLP-1 side effects. Temperature dysregulation represents a largely undocumented consequence that affects quality of life for many patients. Some users report needing to change clothes multiple times daily or adjusting thermostats frequently to find comfort.
The hot flashes resemble those experienced during menopause but occur independently of hormonal changes. Chills can strike suddenly, leaving patients shivering despite warm environments. These symptoms typically persist for weeks or months as the body adapts to sustained weight loss.
Patients benefit from understanding that temperature regulation problems represent a normal physiological response rather than a dangerous complication. The symptoms generally resolve as metabolic adaptation completes. Layered clothing strategies and staying hydrated help manage discomfort during the adjustment period.
Anyone starting GLP-1 therapy should discuss all potential side effects with their prescribing doctor, including temperature fluctuations. Knowing what to expect allows patients to prepare psychologically and practically. Keeping a symptom log helps distinguish GLP-1 related effects from other conditions. Open communication with healthcare providers ensures patients receive appropriate support throughout their treatment journey.